Medtronic Plc has been the subject of substantial investor activity, with selling by
Voya Investment Management LLC,
Perkins Coie Trust Co,
Northern Trust Corp,
Westwood Holdings Group Inc, and
NewEdge Advisors LLC, alongside purchasing by institutions like
cQuantinno Capital Management LP and
Invesco Ltd. A number of companies including
The Manufacturers Life Insurance Company and
Ameriprise Financial Inc. have increased their holdings in MDT. Looking at MDT's financial performance, it reported promising Q2 2026 performance, showing
strong EPS and revenue growth. The company also reported a solid Q1 2026 financial performance. Interesting update is the
filing of an IPO registration for MDT's Diabetes business,
MiniMed. Despite the financial positivity, worries persist about MDT's weak fundamentals with the stock dropping possibly due to the
weak financial prospects. Additionally, Wall Street Zen has upgraded MDT to
'Buy' and analysts have given it a consensus rating of
'Moderate Buy'. MDT's CEO received positive comments from
Jim Cramer, adding to the company's credibility.
Medtronic Plc MDT News Analytics from Tue, 19 Aug 2025 07:00:00 GMT to Sat, 20 Dec 2025 14:06:16 GMT -
Rating 3
- Innovation 2
- Information 7
- Rumor -5
